Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report) shares hit a new 52-week high on Wednesday . The company traded as high as $26.06 and last traded at $25.57, with a volume of 88111 shares trading hands. The stock had previously closed at $24.58.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on KMTS shares. Piper Sandler initiated coverage on Kestra Medical Technologies in a report on Monday. They set an “overweight” rating and a $27.00 target price on the stock. Bank of America began coverage on Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $30.00 price objective for the company. The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued a “neutral” rating and a $24.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a research note on Monday. They set a “buy” rating and a $28.00 price objective on the stock. Finally, Wells Fargo & Company initiated coverage on shares of Kestra Medical Technologies in a report on Monday. They issued an “overweight” rating and a $28.00 price objective on the stock. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Kestra Medical Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $27.67.
Read Our Latest Stock Report on Kestra Medical Technologies
Kestra Medical Technologies Trading Up 4.6 %
Kestra Medical Technologies Company Profile
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Recommended Stories
- Five stocks we like better than Kestra Medical Technologies
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to trade using analyst ratings
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What does consumer price index measure?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.